Stefan Woxström, Senior Vice President, Europe & Canada, AstraZeneca
>75 investors and >10 scouting/business development executives from pharma/diagnostic companies are expected at an exclusive event with max. 200 participants in total
Pitch your product & business model to leading investors & pharma and get your innovation to the direct attention of real decision makers
Book 1-on-1 meetings online now and meet with your potential partners face-to-face in Zurich - over 400 meetings in one afternoon
Switzerland & Sweden regularly launch a "Switzerland-Sweden Call for R&D Project Outlines" within the EUREKA and Eurostars programs. Read more here.
This high-level Swiss-Nordic exclusive investement and partnering meeting gathers Europe´s leading executives from biotech, pharmaceutical, medtech and diagnostic companies as well as investors from Switzerland and the Nordic countries
With Per Falk, President at Ferring Pharmaceuticals
The conference will take place in Zurich in 7 March 2024.
End of registration
28 February 2024
1-to-1 meeting booking open
8 January 2024
Event date
7 March 2024